Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Aurobindo Phar Aurobindo Pharma Ltd. | BSE 1190.05 -8.95 (-0.75%) | NSE 1186.30 -13.80 (-1.15%) | Trade | Add

BSE Live

Dec 30, 16:01

1190.05 -8.95 (-0.75%)

Volume

AVERAGE VOLUME

5-Day

8,009

10-Day

33,527

30-Day

20,995

7,890

Prev. Close

1199.00
Open Price

1190.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 30, 15:59

1186.30 -13.80 (-1.15%)

Volume

AVERAGE VOLUME

5-Day

609,227

10-Day

684,963

30-Day

756,946

1,058,434

Prev. Close

1200.10
Open Price

1202.00

Bid Price (Qty.)
1186.30 (244)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Aurobindo Pharma (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	29.20	29.15	29.12	29.11	29.11
Total Share Capital	29.20	29.15	29.12	29.11	29.11
Reserves and Surplus	5,126.71	3,721.00	2,576.64	2,310.54	2,415.72
Total Reserves and Surplus	5,126.71	3,721.00	2,576.64	2,310.54	2,415.72
Total Shareholders Funds	5,155.91	3,750.15	2,605.76	2,339.65	2,444.83
Minority Interest	25.82	25.67	11.00	10.21	9.12
NON-CURRENT LIABILITIES
Long Term Borrowings	1,361.47	1,279.36	1,148.26	964.63	523.35
Deferred Tax Liabilities [Net]	210.53	205.42	68.00	3.85	123.40
Other Long Term Liabilities	0.00	0.00	0.00	0.00	0.00
Long Term Provisions	24.35	9.18	9.00	4.24	3.09
Total Non-Current Liabilities	1,596.35	1,493.96	1,225.26	972.72	649.84
CURRENT LIABILITIES
Short Term Borrowings	2,502.08	2,354.56	2,236.12	1,608.21	1,234.73
Trade Payables	2,051.12	1,351.20	968.74	660.14	776.35
Other Current Liabilities	1,364.96	387.68	150.87	580.34	699.09
Short Term Provisions	218.24	126.60	80.09	66.36	58.32
Total Current Liabilities	6,136.40	4,220.04	3,435.82	2,915.05	2,768.49
Total Capital And Liabilities	12,914.48	9,489.82	7,277.84	6,237.63	5,872.28
ASSETS
NON-CURRENT ASSETS
Tangible Assets	2,864.97	2,512.02	2,439.05	1,987.21	1,602.44
Intangible Assets	840.67	209.65	199.82	207.44	136.16
Capital Work-In-Progress	0.00	0.00	0.00	0.00	0.00
Fixed Assets	4,125.27	3,031.39	2,857.38	2,840.06	2,396.02
Non-Current Investments	0.14	19.76	22.24	19.86	38.49
Deferred Tax Assets [Net]	4.75	0.05	0.00	5.43	4.35
Long Term Loans And Advances	455.27	789.04	242.81	108.12	110.77
Other Non-Current Assets	30.25	18.40	18.66	0.12	1.47
Total Non-Current Assets	4,615.68	3,858.64	3,141.09	2,973.59	2,551.10
CURRENT ASSETS
Current Investments	19.65	0.03	0.04	18.68	0.04
Inventories	3,611.30	2,367.54	1,923.59	1,545.56	1,455.27
Trade Receivables	3,539.17	2,636.57	1,596.98	1,239.96	1,230.98
Cash And Cash Equivalents	469.11	178.58	208.45	70.86	186.72
Short Term Loans And Advances	568.42	377.19	332.08	314.85	423.04
OtherCurrentAssets	91.15	71.27	75.61	74.13	25.13
Total Current Assets	8,298.80	5,631.18	4,136.75	3,264.04	3,321.18
Total Assets	12,914.48	9,489.82	7,277.84	6,237.63	5,872.28
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00
BONUS DETAILS
Bonus Equity Share Capital	17.35	17.35	17.35	17.35	17.35
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	0.14	19.76	22.24	19.86	38.49
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.03	0.03	0.04	0.05	0.07
Current Investments Unquoted Book Value	19.62	0.00	0.00	18.64	0.00